| Serial Number | 90505170 |
| Word Mark | VIVOZON |
| Filing Date | Tuesday, February 2, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 7, 2023 |
| Registration Number | 6994147 |
| Registration Date | Tuesday, March 7, 2023 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 20, 2022 |
| Description of Mark | The mark consists of the word "VIVOZON" in blue, with a capsule shape inside both "O"s in the word. To the left of "VIVOZON" appears a ribbon / bow design in blue, yellow, red and pink. |
| Goods and Services | Pharmaceutical preparations for immunity adjustment; vaccines; vitamin preparations; preparations of trace elements being nutritional supplements for human and animal use; dietary supplements; dietetic food supplements; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; ferments for pharmaceutical purposes; chemico-pharmaceutical preparations, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; chemical preparations for sanitary use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; bacteriological preparations for medical and veterinary use; biotechnological preparations for medical purposes, namely, analgesic preparations, anti-inflammatory preparations, antipyretic preparations, and anti-itch ointment; biochemical preparations for medical purposes for the treatment of central nervous system diseases, pain, inflammation and skin disorders; sanitary preparations for medical use; medicines for human purposes for the treatment of central nervous system diseases, pain, inflammation and skin disorders; veterinary preparations for the treatment of central nervous system diseases, pain, inflammation and skin disorders; nutraceutical preparations for therapeutic or medical purposes for the treatment of central nervous system diseases, pain, inflammation and skin disorders; nutraceuticals for use as dietary supplements |
| Indication of Colors claimed | The color(s) blue, red, yellow and pink is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 5, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VIVOZON HOLDINGS, INC. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | GYEONGGI-DO KR |
| Party Name | Vivozon, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Yongin-si, Gyeonggi-do . KR |
| Party Name | Vivozon, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Yongin-si, Gyeonggi-do . KR |
| Party Name | Vivozon, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Yongin-si, Gyeonggi-do . KR |
| Event Date | Event Description |
| Friday, February 5, 2021 | NEW APPLICATION ENTERED |
| Wednesday, May 5, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 6, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, August 23, 2021 | ASSIGNED TO EXAMINER |
| Friday, September 3, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, September 3, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, September 3, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, September 3, 2021 | ASSIGNED TO LIE |
| Tuesday, September 7, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, September 7, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 22, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 12, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 12, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 7, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, May 6, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 6, 2022 | SOU EXTENSION 1 FILED |
| Friday, May 6, 2022 | SOU EXTENSION 1 GRANTED |
| Tuesday, May 10, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 16, 2022 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Tuesday, October 18, 2022 | ASSIGNED TO PETITION STAFF |
| Monday, October 24, 2022 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Monday, October 24, 2022 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
| Wednesday, November 16, 2022 | ATTORNEY REVIEW COMPLETED |
| Thursday, November 17, 2022 | NOTICE OF ALLOWANCE CANCELLED |
| Thursday, November 17, 2022 | 1(B) BASIS DELETED; NEW BASIS REQUESTED |
| Wednesday, November 30, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 20, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 20, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 7, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 7, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, September 25, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, November 14, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Thursday, November 14, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, November 14, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, November 14, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |